DNA repair in neural cells: Basic science and clinical implications

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 509, Issue 1-2, 2002, Pages 93-108

  Brooks, P J ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Mismatch repair; Neurodegeneration; Neurogenesis; Oxidative damage; Oxytocin; Recombination

Indexed keywords

DNA;

AGING; ATAXIA TELANGIECTASIA; BACTERIAL GENETICS; CELL DIVISION; CELL POPULATION; CENTRAL NERVOUS SYSTEM; COCKAYNE SYNDROME; DNA REPAIR; DNA SYNTHESIS; GIANT CELL; HUMAN; MUTAGENESIS; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION; XERODERMA PIGMENTOSUM;

BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 0037202610     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(02)00222-1     Document Type: Article

References (147)

1. Bridges B.A. DNA turnover and mutation in resting cells. Bioessays. 19:1997;347-352.
2. Bridges B.A. Dirty transcripts from clean DNA. Science. 284:1999;62-63.
3. E.R. Kandel, Nerve cells and behavior, in: E.R. Kandel, J. Schwartz, T. Jessel (Eds.), Principles of Neural Science, Elsevier, New York, 1991, pp. 19-32.
4. Flaherty D.M., Monick M.M., Hunninghake G.W. AP endonucleases and the many functions of Ref-1. Am. J. Respir. Cell. Mol. Biol. 25:2001;664-667.
5. Wilson T.M.et al. Differential expression of the apurinic/apyrimidinic endonuclease (APE/ref-1) multifunctional DNA base excision repair gene during fetal development and in adult rat brain and testis. Mutat. Res. 362:1996;237-248.
6. Duguid J.R.et al. Differential cellular and subcellular expression of the human multifunctional apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme. Cancer Res. 55:1995;6097-6102.
7. Meira L.B.et al. Heterozygosity for the mouse Apex gene results in phenotypes associated with oxidative stress. Cancer Res. 61:2001;5552-5557.
8. Verjat T.et al. Detection of 8-oxoG DNA glycosylase activity and OGG1 transcripts in the rat CNS. Mutat. Res. 460:2000;127-138.
9. Araneda S.et al. Expression of Kin17 and 8-OxoG DNA glycosylase in cells of rodent and quail central nervous system. Brain Res. Bull. 56:2001;139-146.
10. Cardozo-Pelaez F.et al. DNA damage, repair, and antioxidant systems in brain regions: a correlative study. Free Radic. Biol. Med. 28:2000;779-785.
11. Cardozo-Pelaez F.et al. Effects of diethylmaleate on DNA damage and repair in the mouse brain. Free Radic. Biol. Med. 33:2002;292-298.
12. 6-methylguanine. Cancer Res. 56:1996;5615-5619.
13. LeDoux S.P., Wilson G.L. Base excision repair of mitochondrial DNA damage in mammalian cells. Prog. Nucleic Acid Res. Mol. Biol. 68:2001;273-284.
14. Bohr V.A. Mitochondrial DNA repair. Prog. Nucleic Acid Res. Mol. Biol. 68:2001;255-256.
15. Ledoux S.P.et al. Glial cell-specific differences in response to alkylation damage. Glia. 24:1998;304-312.
16. Hollensworth S.B.et al. Glial cell type-specific responses to menadione-induced oxidative stress. Free Radic. Biol. Med. 28:2000;1161-1174.
17. Chen D.et al. Detection of DNA base-excision repair activity for oxidative lesions in adult rat brain mitochondria. J. Neurosci. Res. 61:2000;225-236.
18. Mandavilli B.S., Ali S.F., Van Houten B. DNA damage in brain mitochondria caused by aging and MPTP treatment. Brain Res. 885:2000;45-52.
19. Brooks P.J., Marietta C., Goldman D. DNA mismatch repair and DNA methylation in adult brain neurons. J. Neurosci. 16:1996;939-945.
20. Brooks P. Detection of excision nuclease in cell-free extracts from the adult mammalian brain. Mutat. Res.-DNA Repair. 408:1998;37-46.
21. Kunishige M.et al. Mutation frequency is reduced in the cerebellum of Big Blue™ mice overexpressing a human wild type SOD1 gene. Mutat. Res. 473:2001;139-149.
22. McEwen B.S.et al. Properties of cell nuclei isolated from various regions of rat brain: divergent characteristics of cerebellar cell nuclei. J. Neurochem. 19:1972;1159-1170.
23. Kisby G.E.et al. Damage and repair of nerve cell DNA in toxic stress. Drug Metab. Rev. 31:1999;589-618.
24. Bohr V.A.et al. DNA repair in an active gene: removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall. Cell. 40:1985;359-369.
25. Mellon I., Spivak G., Hanawalt P.C. Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell. 51:1987;241-249.
26. Hanawalt P. Transcription-coupled repair and human disease. Science. 266:1994;1957-1958.
27. Nouspikel T., Hanawalt P.C. Terminally differentiated human neurons repair transcribed genes but display attenuated global DNA repair and modulation of repair gene expression. Mol. Cell. Biol. 20:2000;1562-1570.
28. Nouspikel T., Hanawalt P. DNA repair in terminally differentiated cells. DNA Repair. 1:2002;59-75.
29. J. Cleaver, K. Kraemer, Xeroderma pigmentosum and Cockayne's syndrome, in: C. Scriver, et al. (Ed.), The Metabolic and Molecular Basis of Inherited Disease, McGraw-Hill, New York, 1995, pp. 4393-4419.
30. Robbins J.H.et al. Neurological disease in xeroderma pigmentosum. Documentation of a late onset type of the juvenile onset form. Brain. 114:1991;1335-1361.
31. E. Friedberg, G. Walker, W. Siede, DNA Repair and Mutagenesis, ASM Press, Washington, DC, 1995, pp. 283-316.
32. Yano K. Xeroderma pigmentosum with disturbance of the central nervous system: a histopathological investigation (translated). Folia Psychiatr. Neurol. Jpn. 4:1950;143-175.
33. Roytta M., Antitnen A. Xeroderma pigmentosum with neurological abnormalities: a clinical and neuropathological study. Acta Neurol. Scand. 73:1986;191-199.
34. Mimaki T.et al. Neurological manifestations in xeroderma pigmentosum. Ann. Neurol. 20:1986;70-75.
35. Itoh M.et al. Neurodegeneration in hereditary nucleotide repair disorders. Brain Dev. 21:1999;326-333.
36. Rapin I.et al. Cockayne's syndrome and xeroderma pigmentosum. Neurology. 55:2000;1442-1449.
37. Satokata I.et al. Characterization of a splicing mutation in group A xeroderma pigmentosum. Proc. Natl. Acad. Sci. U.S.A. 87:1990;9908-9912.
38. Maeda T.et al. Chronological difference in walking impairment among Japanese group A xeroderma pigmentosum (XP-A) patients with various combinations of mutation sites. Clin. Genet. 48:1995;225-231.
39. Maeda T.et al. PCR-RFLP analysis as an aid to genetic counseling of families of Japanese patients with group A xeroderma pigmentosum. J. Invest. Dermatol. 109:1997;306-309.
40. de Laat W.L., Jaspers N.G., Hoeijmakers J.H. Molecular mechanism of nucleotide excision repair. Genes Dev. 13:1999;768-785.
41. States J.C., Myrand S.P. Splice site mutations in a xeroderma pigmentosum group A patient with delayed onset of neurological disease. Mutat. Res. 363:1996;171-177.
42. States J.C.et al. Distribution of mutations in the human xeroderma pigmentosum group A gene and their relationships to the functional regions of the DNA damage recognition protein. Hum. Mutat. 12:1998;103-113.
43. Drapkin R.et al. Dual role of TFIIH in DNA excision repair and in transcription by RNA polymerase II. Nature. 368:1994;769-772.
44. Schaeffer L.et al. The ERCC2/DNA repair protein is associated with the class II BTF2/TFIIH transcription factor. EMBO J. 13:1994;2388-2392.
45. Berneburg M., Lehmann A.R. Xeroderma pigmentosum and related disorders: defects in DNA repair and transcription. Adv. Genet. 43:2001;71-102.
46. Lehmann A.R. The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases. Genes Dev. 15:2001;15-23.
47. Robbins J.H., Brumback R.A., Moshell A.N. Clinically asymptomatic xeroderma pigmentosum neurological disease in an adult: evidence for a neurodegeneration in later life caused by defective DNA repair. Eur. Neurol. 33:1993;188-190.
48. Robbins J.H.et al. Adult-onset xeroderma pigmentosum neurological disease - observations in an autopsy case. Clin. Neuropathol. 21:2002;18-23.
49. Sijbers A.M.et al. Homozygous R788W point mutation in the XPF gene of a patient with xeroderma pigmentosum and late-onset neurologic disease. J. Invest. Dermatol. 110:1998;832-836.
50. Matsumura Y.et al. Characterization of molecular defects in xeroderma pigmentosum group F in relation to its clinically mild symptoms. Hum. Mol. Genet. 7:1998;969-974.
51. Andrews A., Barrett S., Robbins J. Xeroderma pigmentosum neurological abnormalities correlate with the colony forming ability after ultraviolet irradiation. Proc. Natl. Acad. Sci. U.S.A. 75:1978;1984-1988.
52. Robbins J.H., Polinsky R.J., Moshell A.N. Evidence that lack of deoxyribonucleic acid repair causes death of neurons in xeroderma pigmentosum. Ann. Neurol. 13:1983;682-684.
53. Satoh M.et al. DNA excision-repair defect of xeroderma pigmentosum prevents removal of a class of oxygen free radical induced base lesions. Proc. Nat'l. Acad. Sci. U.S.A. 90:1993;6335-6339.
54. Kuraoka I.et al. Removal of oxygen free-radical-induced 5′,8-purine cyclodeoxynucleosides from DNA by the nucleotide excision-repair pathway in human cells. Proc. Natl. Acad. Sci. U.S.A. 97:2000;3832-3837.
55. Brooks P.J.et al. The oxidative DNA lesion 8,5′-(S)-cyclo-2′-deoxyadenosine is repaired by the nucleotide excision repair pathway and blocks gene expression in mammalian cells. J. Biol. Chem. 275:2000;22355-22362.
56. Kuraoka I.et al. Oxygen free radical damage to DNA. Translesion synthesis by human DNA polymerase eta and resistance to exonuclease action at cyclopurine deoxynucleoside residues. J. Biol. Chem. 276:2001;49283-49288.
57. Wang J., Takagaki Y., Manley J. Targeted disruption of an essential vertebrate gene: ASF/SF2 is required for cell viability. Genes Dev. 10:1996;2588-2599.
58. Ljungman M., Zhang F. Blockage of RNA polymerase as a possible trigger for UV light-induced apoptosis. Oncogene. 13:1996;823-831.
59. 32P -postlabeling assay for the oxidative DNA lesion 8,5′-cyclo-2′-deoxyadenosine in mammalian tissues: evidence that four type II I-compounds are dinucleotides containing the lesion in the 3′-nucleotide J. Biol. Chem. 276:2001;36051-36057.
60. Otsuka F., Robbins J.H. The Cockayne's syndrome: an inherited multisystem disorder with cutaneous photosensitivity and defective repair of DNA. Comparison with xeroderma pigmentosum. Am. J. Dermatopathol. 7:1985;387-392.
61. Soffer D.et al. Cockayne's syndrome: unusual neuropathological findings and review of the literature. Ann. Neurol. 6:1979;340-348.
62. Ozdirim E.et al. Cockayne's syndrome: review of 25 cases. Pediatr. Neurol. 15:1996;312-316.
63. Leech R.W.et al. Cockayne's syndrome: clinicopathologic and tissue culture studies of affected siblings. J. Neuropathol. Exp. Neurol. 44:1985;507-519.
64. Svejstrup J.Q. Mechanisms of transcription-coupled DNA repair. Nat. Rev. Mol. Cell. Biol. 3:2002;21-29.
65. Leadon S.A., Cooper P.K. Preferential repair of ionizing radiation-induced damage in the transcribed strand of an active human gene is defective in Cockayne's syndrome. Proc. Natl. Acad. Sci. U.S.A. 90:1993;10499-10503.
66. Cooper P.K.et al. Defective transcription-coupled repair of oxidative base damage in Cockayne's syndrome patients from XP group G. Science. 275:1997;990-993.
67. Le Page F.et al. Transcription-coupled repair of 8-oxoguanine: requirement for XPG, TFIIH, and CSB and implications for Cockayne's syndrome. Cell. 101:2000;159-171.
68. Tuo J.et al. The Cockayne's syndrome group B gene product is involved in general genome base excision repair of 8-hydroxyguanine in DNA. J. Biol. Chem. 276:2001;45772-45779.
69. Balajee A.S.et al. Reduced RNA polymerase II transcription in intact and permeabilized Cockayne's syndrome group B cells. Proc. Natl. Acad. Sci. U.S.A. 94:1997;4306-4311.
70. Baumann N., Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol. Rev. 81:2001;871-927.
71. Burcham P.C. Genotoxic lipid peroxidation products: their DNA damaging properties and role in formation of endogenous DNA adducts. Mutagenesis. 13:1998;287-305.
72. Murai M.et al. Early postnatal ataxia and abnormal cerebellar development in mice lacking xeroderma pigmentosum Group A and Cockayne's syndrome group B DNA repair genes. Proc. Natl. Acad. Sci. U.S.A. 98:2001;13379-13384.
73. Dobbing J., Sands J. Comparative aspects of the brain growth spurt. Early Hum. Dev. 3:1979;79-83.
74. Randerath E., Zhou G.D., Randerath K. Organ-specific oxidative DNA damage associated with normal birth in rats. Carcinogenesis. 17:1996;2563-2570. [corrected and republished in Carcinogenesis 1997 April;18(4):859-866].
75. Randerath K.et al. Enhanced levels in neonatal rat liver of 7,8-dihydro-8-oxo-2′-deoxyguanosine (8-hydroxydeoxyguanosine), a major mutagenic oxidative DNA lesion. Carcinogenesis. 18:1997;1419-1421.
76. Stankovic T.et al. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am. J. Hum. Genet. 62:1998;334-345.
77. Hernandez D.et al. A family showing no evidence of linkage between the ataxia telangiectasia gene and chromosome 11q22-23. J. Med. Genet. 30:1993;135-140.
78. Stewart G.S.et al. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell. 99:1999;577-587.
79. Vinters H.V., Gatti R.A., Rakic P. Sequence of cellular events in cerebellar ontogeny relevant to expression of neuronal abnormalities in ataxia-telangiectasia. Kroc. Found. Ser. 19:1985;233-255.
80. Gatti R.A., Vinters H.V. Cerebellar pathology in ataxia-telangiectasia: the significance of basket cells. Kroc. Found. Ser. 19:1985;225-232.
81. Paula-Barbosa M.M.et al. Cerebellar cortex ultrastructure in ataxia-telangiectasia. Ann. Neurol. 13:1983;297-302.
82. C. Ghez, The cerebellum, in: E.R. Kandel, J. Schwartz, T. Jessel (Eds.), Principles of Neural Science, Elsevier, New York, 1991, pp. 627-646.
83. D'Amours D., Jackson S.P. The Mre11 complex: at the cross-roads of DNA repair and checkpoint signaling. Nat. Rev. Mol. Cell. Biol. 3:2002;317-327.
84. Carney J.P.et al. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell. 93:1998;477-486.
85. Haber J.E. The many interfaces of Mre11. Cell. 95:1998;583-586.
86. Paull T.T., Gellert M. The 3′ to 5′ exonuclease activity of Mre 11 facilitates repair of DNA double-strand breaks. Mol. Cell. 1:1998;969-979.
87. de Jager M.et al. DNA-binding and strand-annealing activities of human Mre11: implications for its roles in DNA double-strand break repair pathways. Nucleic Acids Res. 29:2001;1317-1325.
88. Savitsky K.et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 268:1995;1749-1753.
89. Lim D.S.et al. ATM phosphorylates p95/NBS1 in an S-phase checkpoint pathway. Nature. 404:2000;613-617.
90. Wu X.et al. ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response. Nature. 405:2000;477-482.
91. Zhao S.et al. Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products. Nature. 405:2000;473-477.
92. Gatei M.et al. ATM-dependent phosphorylation of nibrin in response to radiation exposure. Nature Genet. 25:2000;115-119.
93. Barnes D.E.et al. Targeted disruption of the gene encoding DNA ligase IV leads to lethality in embryonic mice. Curr. Biol. 8:1998;1395-1398.
94. Lee Y.et al. Defective neurogenesis resulting from DNA ligase IV deficiency requires ATM. Genes Dev. 14:2000;2576-2580.
95. Sekiguchi J.et al. Genetic interactions between ATM and the non-homologous end-joining factors in genomic stability and development. Proc. Natl. Acad. Sci. U.S.A. 98:2001;3243-3248.
96. Herzog K.H.et al. Requirement for ATM in ionizing radiation-induced cell death in the developing central nervous system. Science. 280:1998;1089-1091.
97. Lee Y., Chong M.J., McKinnon P.J. Ataxia telangiectasia mutated-dependent apoptosis after genotoxic stress in the developing nervous system is determined by cellular differentiation status. J. Neurosci. 21:2001;6687-6693.
98. Stewart G.S.et al. Residual ataxia telangiectasia mutated protein function in cells from ataxia telangiectasia patients, with 5762ins137 and 7271T → G mutations, showing a less severe phenotype. J. Biol. Chem. 276:2001;30133-30141.
99. Allen D.M.et al. Ataxia telangiectasia mutated is essential during adult neurogenesis. Genes Dev. 15:2001;554-566.
100. Barlow C.et al. ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation. Proc. Natl. Acad. Sci. U.S.A. 97:2000;871-876.
101. Oka A., Takashima S. Expression of the ataxia-telangiectasia gene (ATM) product in human cerebellar neurons during development. Neurosci. Lett. 252:1998;195-198.
102. Jeggo P.A., Carr A.M., Lehmann A.R. Splitting the ATM: distinct repair and checkpoint defects in ataxia-telangiectasia. Trends Genet. 14:1998;312-316.
103. Cornforth M.N., Bedford J.S. On the nature of a defect in cells from individuals with ataxia-telangiectasia. Science. 227:1985;1589-1591.
104. Pfeiffer P., Goedecke W., Obe G. Mechanisms of DNA double-strand break repair and their potential to induce chromosomal aberrations. Mutagenesis. 15:2000;289-302.
105. Stern N.et al. Accumulation of DNA damage and reduced levels of nicotine adenine dinucleotide in the brains of ATM-deficient mice. J. Biol. Chem. 277:2002;602-608.
106. Maser R.S., Zinkel R., Petrini J.H. An alternative mode of translation permits production of a variant NBS1 protein from the common Nijmegen breakage syndrome allele. Nature Genet. 27:2001;417-421.
107. Quick K.L., Dugan L.L. Superoxide stress identifies neurons at risk in a model of ataxia-telangiectasia. Ann. Neurol. 49:2001;627-635.
108. Barzilai A., Rotman G., Shiloh Y. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair. 1:2002;3-25.
109. Lim D.S.et al. ATM binds to β-adaptin in cytoplasmic vesicles. Proc. Natl. Acad. Sci. U.S.A. 95:1998;10146-10151.
110. Marietta C.et al. Expression of long-patch and short-patch DNA mismatch repair proteins in the embryonic and adult mammalian brain. Brain Res. Mol. Brain Res. 53:1998;317-320.
111. Belloni M.et al. Distribution and kainate-mediated induction of the DNA mismatch repair protein MSH2 in rat brain. Neuroscience. 94:1999;1323-1331.
112. David P. DNA replication and postreplication mismatch repair in cell-free extracts from cultured human neuroblastoma and fibroblast cells. J. Neurosci. 17:1997;8711-8720.
113. Belloni M.et al. Induction of two DNA mismatch repair proteins, MSH2 and MSH6, in differentiated human neuroblastoma SH-SY5Y cells exposed to doxorubicin. J. Neurochem. 72:1999;974-979.
114. Osheroff W.P.et al. The fidelity of DNA polymerase β during distributive and processive DNA synthesis. J. Biol. Chem. 274:1999;3642-3650.
115. Waser J.et al. DNA polymerase β from brain neurons is a repair enzyme. Eur. J. Biochem. 97:1979;361-368.
116. Sekiguchi J.M.et al. Non-homologous end-joining proteins are required for V(D)J recombination, normal growth, and neurogenesis. Cold Spring Harbor Symp. Quant. Biol. 64:1999;169-181.
117. Essers J.et al. Homologous and non-homologous recombination differentially affect DNA damage repair in mice. EMBO J. 19:2000;1703-1710.
118. O'Driscoll M.et al. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol. Cell. 8:2001;1175-1185.
119. Kleier S.et al. Clinical presentation and mutation identification in the NBS1 gene in a boy with Nijmegen breakage syndrome. Clin. Genet. 57:2000;384-387.
120. Gu Y.et al. Ku70-deficient embryonic stem cells have increased ionizing radiosensitivity, defective DNA end-binding activity, and inability to support V(D)J recombination. Proc. Natl. Acad. Sci. U.S.A. 94:1997;8076-8081.
121. Nussenzweig A.et al. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature. 382:1996;551-555.
122. Kurumizaka H.et al. Homologous-pairing activity of the human DNA-repair proteins Xrcc3.Rad51C. Proc. Natl. Acad. Sci. U.S.A. 98:2001;5538-5543.
123. Johnson R.D., Jasin M. Double-strand-break-induced homologous recombination in mammalian cells. Biochem. Soc. Trans. 29:2001;196-201.
124. Dosanjh M.K.et al. Isolation and characterization of RAD51C, a new human member of the RAD51 family of related genes. Nucleic Acids Res. 26:1998;1179-1184.
125. Thacker J. A surfeit of RAD51-like genes? Trends Genet. 15:1999;166-168.
126. Liu N.et al. Involvement of Rad51C in two distinct protein complexes of Rad51 paralogs in human cells. Nucleic Acids Res. 30:2002;1009-1015.
127. Wiese C.et al. Interactions involving the Rad51 paralogs Rad51C and XRCC3 in human cells. Nucleic Acids Res. 30:2002;1001-1008.
128. Masson J.Y.et al. Identification and purification of two distinct complexes containing the five RAD51 paralogs. Genes Dev. 15:2001;3296-3307.
129. Angulo J.F.et al. Identification of a mouse cDNA fragment whose expressed polypeptide reacts with anti-recA antibodies. Biochimie. 73:1991;251-256.
130. Tissier A.et al. The mouse Kin-17 gene codes for a new protein involved in DNA transactions and is akin to the bacterial RecA protein. Biochimie. 77:1995;854-860.
131. Mazin A.et al. KIN17, a mouse nuclear protein, binds to bent DNA fragments that are found at illegitimate recombination junctions in mammalian cells. Mol. Gen. Genet. 244:1994;435-438.
132. Araneda S.et al. Preferential expression of kin, a nuclear protein binding to curved DNA, in the neurons of the adult rat. Brain Res. 762:1997;103-113.
133. Gellert M. Recent advances in understanding V(D)J recombination. Adv. Immunol. 64:1997;39-64.
134. Chun J.J.et al. The recombination activating gene-1 (RAG-1) transcript is present in the murine central nervous system. Cell. 64:1991;189-200.
135. Schatz D.G., Chun J.J. V(D)J recombination and the transgenic brain blues. New Biol. 4:1992;188-196.
136. Wu Q., Maniatis T. A striking organization of a large family of human neural cadherin-like cell adhesion genes. Cell. 97:1999;779-790.
137. Mohr E.et al. Somatic non-homologous crossing-over between neuropeptide genes in rat hypothalamic neurons. Proc. Natl. Acad. Sci. U.S.A. 91:1994;11403-11407.
138. Finch C.E., Goodman M.F. Relevance of adaptive mutations arising in non-dividing cells of microorganisms to age-related changes in mutant phenotypes of neurons. Trends Neurosci. 20:1997;501-507.
139. Elliott B., Jasin M. Repair of double-strand breaks by homologous recombination in mismatch repair-defective mammalian cells. Mol. Cell. Biol. 21:2001;2671-2682.
140. Gage F.H. Neurogenesis in the adult brain. J. Neurosci. 22:2002;612-613.
141. Rakic P. Adult neurogenesis in mammals: an identity crisis. J. Neurosci. 22:2002;614-618.
142. Gould E., Gross C.G. Neurogenesis in adult mammals: some progress and problems. J. Neurosci. 22:2002;619-623.
143. Alvarez-Buylla A., Garcia-Verdugo J.M. Neurogenesis in adult subventricular zone. J. Neurosci. 22:2002;629-634.
144. Kempermann G. Why new neurons? Possible functions for adult hippocampal neurogenesis. J. Neurosci. 22:2002;635-638.
145. Kintner C. Neurogenesis in embryos and in adult neural stem cells. J. Neurosci. 22:2002;639-643.
146. Cooper-Kuhn C.M., Georg Kuhn H. Is it all DNA repair? Methodological considerations for detecting neurogenesis in the adult brain. Brain Res. Dev. Brain Res. 134:2002;13-21.
147. Yang Y., Geldmacher D.S., Herrup K. DNA replication precedes neuronal cell death in Alzheimer's disease. J. Neurosci. 21:2001;2661-2668.